June 11, 2021


DSM-Novozymes alliance launches its second-generation protease for poultry




The DSM-Novozymes Feed Enzymes Alliance announced earlier this week the commercial release of its breakthrough second-generation protease, ProAct 360™.

ProAct 360 sets a new market standard in protease technology for poultry on three key fronts: feed efficiency, affordability, and sustainability. The feed solution delivers more consistent improvements in growth performance, along with improved matrix values for key amino acids and faster action. As its name suggests, ProAct 360 reflects a 360° understanding of the needs of poultry producers, and also of the challenges that poultry production can face with regard to environmental footprint.

The new protease helps feed producers to be more flexible in their selection and use of raw materials, reducing the industry's reliance on soybean and other major crops while at the same time helping to cut feed costs. It also significantly enhances the digestibility of protein, ensuring greater retention of nitrogen in metabolism and therefore lower nitrogen emissions to the environment.

ProAct 360 therefore offers improved returns on investment and its value proposition goes beyond the product itself. It includes a unique set of value-adding, end-to-end digital services, ranging from raw material analysis to a sustainability calculator, that enable deeper insights and more informed decision-making.

Christie Chavis, vice president at DSM Animal Nutrition and Health, observes: "ProAct 360 is our latest breakthrough technology in sustainability-driven innovation. Improving sustainability while reducing feed costs and supporting animal welfare is the key requirement for the animal protein industry today. The launch of ProAct 360 is an important proof point of our strategic initiative We Make it Possible, which is designed to deliver solutions that enable the transition to fully sustainable animal protein production worldwide."

Robert Vergo, Account Director, global strategic accounts at Novozymes, says: "ProAct 360 is the latest of many ground-breaking innovations from the DSM-Novozymes Feed Enzymes Alliance. Selected via a rigorous screening process involving more than 500 protease candidates, it is a novel and robust protease product tailored to the needs of today's feed industry."

ProAct 360 will initially be launched in the markets of Latin America, with a roll-out to the other regions of the world to follow in the medium term. Future swine applications are being studied.